ABBOTT LABORATORIES cotiza a 103.07 USD y tiene una capitalización bursátil de $178.4B. En los últimos 12 meses ha facturado $45.1B con un margen de flujo de caja libre del 16.7%. Cotiza a 24.2 veces su flujo de caja libre (P/FCF) y a un PER de 28.4. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatmen…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-01 |
|---|---|---|---|---|
| Real | — | $1.31 | $1.15 | $1.50 |
| Estimado | $1.42 | $1.28 | $1.15 | $1.49 |
| Sorpresa | — | +2.3% | +0.0% | +0.7% |
| Métrica | ABT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 56.4% | 57.0% | -0.6% |
| Operating Margin | 18.2% | -38.6% | +56.8% |
| Net Margin | 14.7% | -33.6% | +48.3% |
| FCF Margin | 16.7% | -13.9% | +30.5% |
| ROE | 12.5% | -40.4% | +52.9% |
| ROA | 7.5% | -32.0% | +39.5% |
| Current Ratio | 1.58 | 2.84 | -1.26 |
| Debt / Equity | 0.25 | 0.28 | -0.03 |